Oral cortico-steroids such as prednisone are usually
reserved for patients with acute exacerbations of asthma symptoms and PEFs
below 50% of predicted. Some patients with exacerbations and PEFs between
50% and 70% are treated with prednisone. This patient has moderate,
persistent asthma. Increasing the dose of his inhaled corticosteroid or
adding a long-acting ß-agonist are both acceptable treatment options.
Since long-term treatment with high-dose inhaled corticosteroids may
lead to complications, adding a long-acting bronchodilator may be preferred.
- Add a long-acting ß-agonist such as salmeterol or formoterol to his
Click here to return to the questions
Seminars in Medical Practice
Hospital Physician Board Review Manuals
Copyright © 2009, Turner White Communications
Updated 1/04/08 kkj